Pregnancy Hypertension

Title Publication Date Language Citations
PO6_05. Restoring the angiogenic imbalance in preeclampsia and fetal growth restriction: is sflt-1 removal sufficient?2023/09/01English
PO6_18. The additive role of the SFLT-1/PLGF ratio among women with preeclampsia for prediction of preeclampsia with severe features within two weeks2023/09/01English
OP05_3. Time-of-disease risk prediction of adverse maternal outcomes of pre-eclampsia using artificial intelligence2023/09/01English
OP07_3. Aspirin for the prevention of preeclampsia and pregnancy outcomes in nulliparous women after assisted reproductive technology: a protocol for a multicenter randomized trial2023/09/01English
PO1_05. Maternal vascular malperfusion of the placenta, hypertensive disorders of pregnancy, newborn and placental growth and fetal sex2023/09/01English
PO2_11. a comparative analysis of neonatal outcomes in pregnancies complicated by preeclampsia and eclampsia in Ghana2023/09/01English
PO6_04. Do lower blood pressure cut-offs in pregnancy predict adverse maternal and fetal outcomes in a nulliparous, standard-risk cohort?2023/09/01English
PO1_07. Non proteinuric preeclampsia: Implications in the diagnosis and clinical and laboratory profile with 2013[StQuote]s new diagnostic criteria2023/09/01English
PO1_13. CANCELLED: Relationship between non-viable pregnancies and the development of severe preeclampsia and hellp syndrome; a pilot study2023/09/01English
OP08_6. Novel therapeutic strategy in pregnancy: prevention of transplacental passage by lipid nanoparticles2023/09/01English
OP10_3. Maternal circulating serum AMYLOID A1 in post-date pregnancies and placenta-associated biomarkers2023/09/01English
OP06_3. Uterine myometrium angiogenesis is associated with hydrogen sulfide biosynthesis in pregnancy and preeclampsian2023/09/01English
PO6_20. The SFLT-1/PLGF ratio for the prediction of preeclampsia-related adverse fetal and maternal outcomes in women with preexisting diabetes2023/09/01English
SC1_1. Methylation of cpg islands as first trimester biomarker for preeclampsia2023/09/01English
PO8_4. Late postpartum eclampsia with multifocal posterior reversible encephalopathy syndrome after twin gestation: a case report2023/09/01English
PO2_13. Correlation of magnesium sulfate use and perinatal death in preeclampsia and eclampsia2023/09/01English
PO1_17. Incidence of hypertensive disorders of pregnancy in Europe2023/09/01English
OP08_2. New generation antiplatelet therapies decrease soluble FMS-like tyrosine kinase-1, enhance antioxidant cytoprotection, rescue vascular and endothelial dysfunction and decrease hypertension in two mouse models of preeclampsia2023/09/01English
PO9_11. Screening for hypertensive disorders of pregnancy in women admitted at referral level hospitals in Uganda2023/09/01English
PO3_13. Preeclampsia and elective anticipation of parturition - contributing factors2023/09/01English
OP02_6. Nationwide pregnancy outcomes after kidney transplantation and prediction of adverse pregnancy outcomes: A Dutch cohort study2023/09/01English
OP19_2. Luteolin, a natural flavonoid, attenuates the development of placental ischemia-induced hypertension in pregnant rats2023/09/01English
PO2_16. Preconceptional counselling in women with a previous pregnancy complicated by preeclampsia2023/09/01English
PO9_02. Expression of components of the renin-angiotensin system (RAS) in adipose tissue in non-pregnant women and pregnant women with and without pre-eclampsia2023/09/01English
SC1_2. Validation of a machine-learning based algorithm to detect preeclampsia-related adverse outcomes on a dataset with different demographic properties than the training dataset2023/09/01English
OP06_2. Childhood growth and neurodevelopmental outcomes 2 years after hypertensive versus normotensive pregnancy2023/09/01English
PO2_15. Long-term impact of previous gestational hypertensive disorders on weight status, blood pressure and arterial stiffness2023/09/01English
PO9_05. Endothelial glycocalyx dysfunction in early- and late-onset preeclampsia2023/09/01English
OP06_4. Circulating concentrations of glyxocalyx degradation products in preeclampsia2023/09/01English
OP09_3. Relationship between vitamin D status and the risk for placenta-mediated complications in pregnancy at high risk: ANGIOPRED VITAD study2023/09/01English